## Clinical Diagnosis: Erythema Infectiosum (Fifth Disease) ### Key Clinical Features **Key Point:** Erythema infectiosum is caused by parvovirus B19 and is characterized by the pathognomonic "slapped cheek" appearance followed by a lacy, reticular rash on the trunk and extremities. ### Characteristic Rash Pattern The rash evolves in three phases: 1. **Phase 1 (Days 1–3):** Bright erythema of cheeks ("slapped cheek" appearance), sparing nasolabial folds and oral mucosa 2. **Phase 2 (Days 3–7):** Lacy, reticular rash on trunk and extremities; may blanch with pressure 3. **Phase 3 (Days 7–14):** Rash may reappear with fever, stress, or sun exposure ### Associated Findings | Feature | Presence in Erythema Infectiosum | | --- | --- | | Fever | Mild, often absent by rash onset | | Arthralgia/arthritis | Common in children (knees, wrists, ankles) | | Lymphadenopathy | Minimal | | Oral involvement | Absent (rash spares oral mucosa) | | Reticulocytosis | Present (due to transient RBC aplasia) | **High-Yield:** The combination of "slapped cheek" rash + lacy reticular rash + reticulocytosis is pathognomonic for parvovirus B19. ### Pathophysiology Parvovirus B19 is a small, non-enveloped DNA virus that: - Infects erythroid progenitor cells in bone marrow - Causes transient arrest of RBC production (reticulocytopenia followed by reticulocytosis) - In immunocompetent children, this is usually asymptomatic; in those with hemolytic anemias (sickle cell, hereditary spherocytosis), it can cause aplastic crisis **Clinical Pearl:** In children with chronic hemolytic anemia, parvovirus B19 can precipitate a life-threatening aplastic crisis with severe anemia and reticulocytopenia. ### Epidemiology - Most common in children aged 5–15 years - Peak incidence in spring - Highly contagious; spreads via respiratory droplets - Schoolchildren are a common source of transmission ### Complications in Special Populations - **Pregnant women (especially first/second trimester):** Risk of hydrops fetalis and fetal loss (10–15%) - **Immunocompromised patients:** Chronic anemia and persistent viremia - **Patients with hemolytic anemias:** Aplastic crisis **Mnemonic:** **FIFTH DISEASE** = **F**ace slapped, **I**nfectious (parvovirus B19), **F**ever mild, **T**hen lacy rash, **H**emolytic risk in sickle cell ### Management 1. **Supportive care:** Antipyretics, fluids, rest 2. **Monitoring:** Serial hemoglobin in high-risk patients (hemolytic anemias) 3. **Isolation:** Not required after rash appears (non-infectious by then) 4. **Pregnancy:** Fetal monitoring if maternal infection in first/second trimester [cite:Park 26e Ch 16]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.